Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 833

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 833
---
 which will be
exchanged for shares of New Semnur Common Stock upon closing of the Business Combination pursuant to the terms of the Merger Agreement.

Consulting Services Agreement with Wise Orient Investments Limited, as amended

On July 22, 2025, the Company entered into an amendment to the consulting services
agreement previously entered with Wise Orient Investments Limited on August 26, 2024. Pursuant to the amendment, among other things, the parties agreed that in exchange for the services provided thereunder, Wise Orient Investments Limited is
issued 3,200,000 shares of Semnur Common Stock as finder and advisory retainer fees, which will be exchanged for shares of New Semnur Common Stock upon closing of the Business Combination pursuant to the terms of the Merger Agreement.

Advisory Services Agreement with JW Investment Management Company Limited, as amended

On June 15, 2025 the Company entered into an advisory services agreement, as amended on July 22, 2025, with JW Investment Management Company Limited
(“JW”), pursuant to which JW agreed to perform certain consulting and advisory services related to the Company’s business, financing, and mergers and acquisitions opportunities for a period of 12 months from the date of the
agreement. In exchange for the services provided, JW is issued 8,000,000 shares of Semnur Common Stock as finder and advisory retainer fees, which will be exchanged for shares of New Semnur Common Stock upon closing of the Business Combination
pursuant to the terms of the Merger Agreement.

Stock Issuance Agreement

On July 22, 2025, Company entered into a stock issuance agreement with the law firm named therein, pursuant to which the law firm is issued 10,000,000 shares
of the Semnur Common Stock as a retainer for legal services and payment for prior services, which will be exchanged for shares of New Semnur Common Stock upon closing of the Business Combination pursuant to the terms of the Merger Agreement.

F-99

Annex A-1

AGREEMENT AND PLAN OF MERGER

dated as of August 30, 2024

by and among

Denali Capital Acquisition Corp.,

Denali Merger Sub Inc.,

and

Semnur Pharmaceuticals, Inc.

TABLE OF CONTENTS

|                                                         |     |                                                                      |     | Page   |
| ARTICLE I DEFINITIONS                                   |     |                                                                      |     | A-1-2  |